Cellino的动态

?? Today marks an extraordinary milestone at Cellino! We are thrilled to announce that our team has been awarded up to $25M in funding from the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS). This funding will drive the development of our ultra-scalable, autonomous, cassette-based advanced biomanufacturing technology for personalized regenerative medicine. Cellino’s NEBULA (NExt-generation Biomanufacturing ULtra-scalable Approach) project is the first project funded by the Scalable Solutions Mission Office under the ARPA-H Open Broad Agency Announcement. With ARPA-H’s support, Cellino will build a cassette-based biomanufacturing technology capable of scaling the production of personalized induced pluripotent stem cells at hospitals nationwide to develop curative medicines for a range of chronic conditions for an increasingly diverse and aging U.S. patient population. We are excited to move closer to making “Your Cells, Your Cure?” a reality for millions of patients. We are thrilled about this opportunity to advance our goal of making patient-specific stem cell-derived therapies available for broad patient audiences. ?? Read the full release: https://bwnews.pr/4gfrjlb #ARPAH #Biotech #AI #MachineLearning #PersonalizedMedicine #Collaboration #Innovation #RegenerativeMedicine #BiotechBreakthroughs #CellinoBio #YourCellsYourCure #Biomanufacturing

???? Cellino is proud to announce the winner of the "CELLebrate Your Cells" voting campaign is… ???? Pancreatic Beta Cells! As we work toward a scalable future where all patients have access to regenerative therapies, our team is inspired by the engagement and interest surrounding this campaign. Voters were asked which cells, tissues, or organs they would prioritize for on-demand printing, and Pancreatic Beta Cells, which play a key role in #diabetes treatment, were selected as the top choice. This campaign highlights the importance of using an autologous approach to revolutionize access to therapies, addressing the unmet needs that continue to persist for patients with chronic conditions.? Cell type runner-ups include: ??? Retinal Pigment Epithelium Cells (Age-Related Macular Degeneration) ?? Dopaminergic Neurons (Parkinson’s Disease) We’re very proud of our team’s progress in building an ultra-scalable #biomanufacturing platform to industrialize the production of personalized medicines as we continue working towards bringing "Your Cells, Your Cure?” to fruition. ?? Follow Cellino as we advance our mission to build transformative health solutions for all patients! #Cellino #Biotech #LifeSciences #Biomanufacturing #CellTypes #RegenMed #Innovation #PersonalizedMedicine #HealthEquity #FutureOfHealthcare #YourCellsYourCure #CELLebrateYourCells

?? We’re proud to announce that Marinna Madrid, PhD, our Co-Founder & Chief Product Officer, will be a keynote speaker at "The Next Wave of the Regenerative Medicine Industry: Integrating AI to Enhance Competitiveness," hosted by the Foundation of Medical Professionals Alliance in Taiwan (#FMPAT) on October 17, 2024. FMPAT, an NGO think tank, collaborates with Taiwan's Ministry of Health and Welfare and Ministry of Economic Affairs to advance regenerative medicine. Marinna will speak on "Reimaging Biomanufacturing of Autologous iPSC-based Therapies: Using AI to increase Scale and Consistency," from 9:55 - 10:35 AM CST at the NTUH International Convention Center. This session will explore Cellino's autonomous #AI- and laser-based process for scaling the production of personalized medicines for a wide range of chronic degenerative conditions. We’re honored to join this important discussion on integrating smart technologies into CGT processes and cultivating impactful partnerships between #Taiwan, #Japan, the #UnitedStates, and the #EuropeanUnion. ?? ? ?? Learn more: https://mpat.org.tw/Home ?? Follow Cellino and turn on your post notifications to stay tuned for more details! #RegenMed #Healthcare #AIinHealthcare #Innovation #Collaboration #Innovation #Therapeutics #PersonalizedMedicine #YourCellsYourCure #CellinoBio

?? As we honor #IndigenousPeoplesDay, we reflect on the importance of Indigenous contributions in accelerating health equity and innovation in #STEM. By amplifying their perspectives, we build pathways for more equitable health outcomes that represent real-world patient diversity. Today, let’s celebrate Indigenous peoples and their impact, listen and learn, and commit to collaboration that delivers improved health outcomes for all. ???? #IndigenousinSTEM #HealthEquity #DiversityandInclusion #Innovation #RegenMed #PersonalizedMedicine #YourCellsYourCure #Cellino

?? Tomorrow is the LAST DAY to vote in our "CELLebrate Your Cells" Campaign! Our automated #biomanufacturing tech stack enables cost-effective and reliable production of personalized cell-based therapies for patients with chronic conditions. ??? If you could print personalized cells, tissues, or organs on demand, what would you make first? Vote now for the #celltype below and show your support for improved health outcomes: - Retinal Pigment Epithelium Cells (Age-related Macular Degeneration) - Pancreatic Beta Cells (Diabetes) - Keratinocytes and Fibroblasts (Epidermolysis Bullosa) - Dermal Papilla Cells (Hair Loss) - Dopaminergic Neurons (Parkinson’s Disease) - Cardiomyocytes (Heart Failure) - Cardiovascular Progenitor Cells (Congenital Heart Disease) - Skeletal Muscle Cells (Muscular Dystrophies) - Neural Stem Cells (Spinal Cord Injury) - Satellite Cells (Muscular Dystrophies) - Smooth Muscle Cells (Urinary Incontinence) ?? Cast your vote here: https://bit.ly/46O2dWn Voting ends tomorrow, Sunday, October 13, 2024, at 11:59 PM EDT. Cast your vote, share this post, and follow Cellino for the results! ?? ?? DISCLAIMER: This poll is for informational purposes only, and the results are non-binding with respect to Cellino's business and scientific decisions. #Cellino #Biotech #LifeSciences #Biomanufacturing #CellTypes #TissueEngineering #RegenerativeMedicine #Innovation #PersonalizedMedicine #HealthEquity #FutureOfHealthcare #YourCellsYourCure #CELLebrateYourCells

?? #Parkinsons disease affects an estimated 1 million people in the United States, making it the second most common #neurodegenerative disorder. Our "CELLebrate Your Cells" campaign highlights the transformative potential of autologous cell and tissue therapies?from treating chronic conditions to pioneering new treatments. For conditions like Parkinson’s, this approach involves creating patient-specific dopaminergic neurons from induced pluripotent stem cells (#iPSCs) and implanting them into the brain. These iPSC-derived neurons offer a promising, personalized therapy that moves beyond traditional treatments, redefining the future of neurodegenerative care. ???? Cast your vote to support the future of personalized medicine and share which cells or tissues you would choose first for on-demand printing. - Retinal Pigment Epithelium Cells (Age-related Macular Degeneration) - Pancreatic Beta Cells (Diabetes) - Keratinocytes and Fibroblasts (Epidermolysis Bullosa) - Dermal Papilla Cells (Hair Loss) - Dopaminergic Neurons (Parkinson’s Disease) - Cardiomyocytes (Heart Failure) - Cardiovascular Progenitor Cells (Congenital Heart Disease) - Skeletal Muscle Cells (Muscular Dystrophies) - Neural Stem Cells (Spinal Cord Injury) - Satellite Cells (Muscular Dystrophies) - Smooth Muscle Cells (Urinary Incontinence) ?? Vote now here: https://bit.ly/46O2dWn ? The winning cell type will be decided by public votes, open until Sunday, October 13, 2024 at 11:59 PM EDT. Vote now, share this post, and follow Cellino to stay updated on the results! ???? ?? Repost and share to join us on the path to make personalized medicines available at scale. ?? DISCLAIMER: This poll is for informational purposes only, and the results are non-binding with respect to Cellino's business and scientific decisions. #Cellino #Biotech #LifeSciences #Biomanufacturing #CellTypes #TissueEngineering #RegenerativeMedicine #Innovation #PersonalizedMedicine #HealthEquity #FutureOfHealthcare #YourCellsYourCure #CELLebrateYourCells

?? We’re celebrating Cellino’s recent ranking as #3 on the 2024 LinkedIn Top Startups List in #Boston! A big thank you to LinkedIn for helping us share our journey and connect with other incredible professionals in #STEM. Hear from our CEO & Co-Founder, Nabiha Saklayen, as she shares her thoughts on this milestone:

?? Around 200 children per year are born with #EpidermolysisBullosa (EB), a genetic skin disorder characterized by extreme skin fragility. For those with this condition, a simple hug or the slightest knock can lead to painful wounds and blistering. Children born with it are often called “Butterfly Children” because their skin seems as fragile as a butterfly wing. Personalized regenerative medicine offers hope by using a patient’s own #keratinocytes and #fibroblasts to repair and strengthen the skin. Cellino's “CELLebrate Your Cells” voting campaign aims to raise awareness of rare and chronic conditions like Epidermolysis Bullosa while supporting transformative alternatives to traditional treatments. ??? #Vote now for the #celltype you would choose for on-demand printing! - Retinal Pigment Epithelium Cells (Age-related Macular Degeneration) - Pancreatic Beta Cells (Diabetes) - Keratinocytes and Fibroblasts (Epidermolysis Bullosa) - Dermal Papilla Cells (Hair Loss) - Dopaminergic Neurons (Parkinson’s Disease) - Cardiomyocytes (Heart Failure) - Cardiovascular Progenitor Cells (Congenital Heart Disease) - Skeletal Muscle Cells (Muscular Dystrophies) - Neural Stem Cells (Spinal Cord Injury) - Satellite Cells (Muscular Dystrophies) - Smooth Muscle Cells (Urinary Incontinence) ??? Vote now here: https://bit.ly/46O2dWn ?? Repost and encourage your colleagues and professional network to vote! Voting ends on Sunday, October 13, 2024 at 11:59 PM EDT. ?? DISCLAIMER: This poll is for informational purposes only, and the results are non-binding with respect to Cellino's business and scientific decisions. #Cellino #Biotech #LifeSciences #Biomanufacturing #CellTypes #TissueEngineering #RegenerativeMedicine #Innovation #PersonalizedMedicine #HealthEquity #FutureOfHealthcare #YourCellsYourCure #CELLebrateYourCells

?? We’re halfway through the voting period for our "CELLebrate Your Cells" Campaign! Our automated #biomanufacturing tech stack enables cost-effective and reliable production of personalized cell-based therapies for patients with chronic conditions. If you could print personalized cells, tissues, or organs on demand, what would you make first? We want to hear your thoughts! ?? ?? #Vote for the #celltype below to show your support for improved health outcomes: - Retinal Pigment Epithelium Cells (Age-related Macular Degeneration) - Pancreatic Beta Cells (Diabetes) - Keratinocytes and Fibroblasts (Epidermolysis Bullosa) - Dermal Papilla Cells (Hair Loss) - Dopaminergic Neurons (Parkinson’s Disease) - Cardiomyocytes (Heart Failure) - Cardiovascular Progenitor Cells (Congenital Heart Disease) - Skeletal Muscle Cells (Muscular Dystrophies) - Neural Stem Cells (Spinal Cord Injury) - Satellite Cells (Muscular Dystrophies) - Smooth Muscle Cells (Urinary Incontinence) ?? Vote now here: https://bit.ly/46O2dWn The winning cell type will be decided by public votes, open until Sunday, October 13, 2024 at 11:59 PM EDT. Vote now, share this post, and follow Cellino to stay updated on the results! ?? ?? DISCLAIMER: This poll is for informational purposes only, and the results are non-binding with respect to Cellino's business and scientific decisions. #Cellino #Biotech #LifeSciences #Biomanufacturing #CellTypes #TissueEngineering #RegenerativeMedicine #Innovation #PersonalizedMedicine #HealthEquity #FutureOfHealthcare #YourCellsYourCure #CELLebrateYourCells